EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Risk Factors for Steatotic Liver Disease After Liver Transplantation

Ville Liukkonen iD, Maria Semenova iD, Kati Hyvärinen iD, Jouni Lauronen iD, Jukka Partanen iD, Johanna Arola iD, Arno Nordin iD, Martti Färkkilä iD, Fredrik Åberg iD

Liver International · 2025

DOI: 10.1111/liv.70067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Ville Liukkonen und 8 weiteren Autor:innen. Beteiligte Einrichtung: North Karelia Central Hospital, Gastroenterology, University of Helsinki, Faculty of Medicine, Helsinki, Finland. Hauptthemen laut MEDLINE: Liver Transplantation, Lipase, Fatty Liver, Membrane Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Mary and Georg C. Ehrnrooth Foundation, Suomalainen Lääkäriseura Duodecim, Government of Finland VTR funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The role of genetic risk factors for steatotic liver disease (SLD) is intriguing in liver transplantation (LT), as both donor and recipient genetic factors may play a role. There are only a few small‐scale studies published so far.

Methods

We analysed the incidence and risk factors for post‐LT SLD and the impact of 56 SLD‐associated genetic variants in 595 donor‐recipient pairs with liver biopsy available ≥ 6 months after LT. We evaluated whether the polygenic risk score (PRS‐5) improves the ability to predict post‐LT SLD in addition to non‐genetic risk factors.

Results

SLD after LT was diagnosed in 34.5% of patients during a median 7.6‐year follow‐up. In multivariate analysis including non‐genetic risk factors, donor PNPLA3 rs738409‐G (HR for SLD: C/G 1.34, p = 0.051, G/G 2.25, p = 0.004), donor HSD17B13 rs72613567‐TA (HR for SLD: TA/T 0.68, p = 0.02 TA/TA HR 0.50, p = 0.10) and recipient UCP2 rs695366‐G (HR for SLD: A/G 0.63, p = 0.002, G/G HR 0.50, p = 0.04) appeared as the most important genetic risk factors for post‐LT SLD. The addition of PRS‐5 to a multivariate regression model (including non‐genetic risk factors) improved the predictive ability for SLD only modestly (AUC 0.78 to 0.80).

Conclusions

Various genetic variants contribute to post‐LT SLD with separate variants among recipients and donors, with donor PNPLA3 rs738409‐G as the most significant risk allele. Still, donor and recipient genotyping provide only modest additional value for individual risk stratification over phenotype data, highlighting the role of modifiable risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationLipaseFatty LiverMembrane ProteinsHumansMaleFemaleRisk FactorsMiddle AgedAdultGenetic Predisposition to DiseasePolymorphism, Single NucleotideIncidenceTissue DonorsLiverMultivariate AnalysisAgedAcyltransferasesPhospholipases A2, Calcium-Independent

Stichwörter der Autor:innen

fatty livergeneticsliver transplantationpolygenic risk scoresteatotic liver disease

Substanzen

PNPLA3 protein, humanLipaseMembrane ProteinsAcyltransferasesPhospholipases A2, Calcium-Independent

Autor:innen und Institutionen

  • North Karelia Central Hospital, Gastroenterology, University of Helsinki, Faculty of Medicine, Helsinki, Finland.
  • Finnish Red Cross Blood Service, Research & Development, Helsinki, Finland.
  • Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Department of Pathology, Helsinki University Hospital, Diagnostic Centre, Helsinki, Finland.
  • Transplantation and Liver Surgery, Helsinki University Hospital, Helsinki, Finland.
  • Transplantation and Liver Surgery, Helsinki University Hospital, University of Helsinki, Faculty of Medicine, Helsinki, Finland.

ORCID-Profile: Ville Liukkonen, Maria Semenova, Kati Hyvärinen, Jouni Lauronen, Jukka Partanen, Johanna Arola, Arno Nordin, Martti Färkkilä, Fredrik Åberg

Förderung

  • The Mary and Georg C. Ehrnrooth Foundation
  • Suomalainen Lääkäriseura Duodecim
  • Government of Finland VTR funding

Zitieren

APA

Liukkonen, V., Semenova, M., Hyvärinen, K., Lauronen, J., Partanen, J., Arola, J., Nordin, A., Färkkilä, M., & Åberg, F. (2025). Genetic Risk Factors for Steatotic Liver Disease After Liver Transplantation. Liver International. https://doi.org/10.1111/liv.70067

Vancouver

Liukkonen V, Semenova M, Hyvärinen K, Lauronen J, Partanen J, Arola J, et al. Genetic Risk Factors for Steatotic Liver Disease After Liver Transplantation. Liver International. 2025. doi:10.1111/liv.70067

BibTeX
@article{Liukkonen2025,
  author = {Liukkonen, Ville and Semenova, Maria and Hyvärinen, Kati and Lauronen, Jouni and Partanen, Jukka and Arola, Johanna and Nordin, Arno and Färkkilä, Martti and Åberg, Fredrik},
  title = {Genetic Risk Factors for Steatotic Liver Disease After Liver Transplantation},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.70067}
}
Kostenlos starten →